From April 1, 2022 to June 30, 2022, the company has repurchased 744,858 shares, representing 2.9% for $2.89 million. With this, the company has completed the repurchase of 2,675,872 shares, representing 10.03% for $11.44 million under the buyback announced on November 17, 2021.
La Jolla Pharmaceutical Company
Equities
LJPC
US5034596040
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.83% | 115B | |
+10.80% | 105B | |
-10.84% | 22.71B | |
-1.22% | 21.83B | |
-10.95% | 18.18B | |
-41.92% | 16.52B | |
-15.11% | 16.01B | |
+6.62% | 14.14B | |
+17.53% | 10.71B |